Table 2.
Clinicopathological variables | N | BLM expression | P value | |
---|---|---|---|---|
Low (55) | High (40) | |||
Sex | 0.208 | |||
Male | 81 | 45 | 36 | |
Female | 14 | 10 | 4 | |
Age, years | 0.171 | |||
< 50 | 48 | 25 | 23 | |
≥ 50 | 47 | 30 | 17 | |
AFP, ng/L | 0.022 | |||
< 200 | 53 | 36 | 17 | |
≥ 200 | 42 | 19 | 23 | |
HBsAg | 0.504 | |||
Negative | 44 | 25 | 19 | |
Positive | 51 | 30 | 21 | |
Tumor size, cm | 0.005 | |||
≤ 5 | 49 | 35 | 14 | |
> 5 | 46 | 20 | 26 | |
Tumor nodule number | 0.01 | |||
Solitary | 57 | 39 | 18 | |
Multiple (≥ 2) | 38 | 16 | 22 | |
Cancer embolus | 0.567 | |||
Absence | 62 | 36 | 16 | |
Presence | 33 | 19 | 14 | |
TNM stage | 0.033 | |||
Early (I & II) | 52 | 35 | 17 | |
Late (III & IV) | 43 | 20 | 23 | |
Differentiation grade | 0.550 | |||
Well | 67 | 39 | 28 | |
Poor | 28 | 16 | 12 |
AFP alpha fetoprotein, HBsAg hepatitis B surface antigen